LDN-193189: Difference between revisions

From XenWiki
Jump to navigation Jump to search
imported>Xenbase
(Added details of LDN-193189)
 
imported>Xenbase
 
Line 3: Line 3:


==Alternative names==
==Alternative names==
1062368-24-4
*1062368-24-4
4-(6-(4-(piperazin-1-yl)phenyl)pyrazolo[1,5-a]pyrimidin-3-yl)quinoline
*4-(6-(4-(piperazin-1-yl)phenyl)pyrazolo[1,5-a]pyrimidin-3-yl)quinoline
CHEMBL513147
*CHEMBL513147
UNII-W69H5YQU9O
*UNII-W69H5YQU9O
LDN193189
*LDN193189


==Usage Notes==
==Usage Notes==

Latest revision as of 10:35, 15 January 2021

Description

LDN-193189 is a selective BMP receptor inhibitor that inhibits transcriptional activity of Alk2 and Alk3 BMP type 1 receptors. Also inhibits Smad1, Smad5 and Smad8 activation.

Alternative names

  • 1062368-24-4
  • 4-(6-(4-(piperazin-1-yl)phenyl)pyrazolo[1,5-a]pyrimidin-3-yl)quinoline
  • CHEMBL513147
  • UNII-W69H5YQU9O
  • LDN193189

Usage Notes

References

> 8 Xenbase articles contain a reference to LDN-193189 according to textpresso